Inactivation of HIV-1 In serum
Stock virus or tenfold dilutions of virus (100 ll) were suspended in 800,l complete medium (CM) or FCS. Disinfectant (100 ,ul) was added, mixed and left for the required test period. The concentration of serum in the test mixture was therefore 8 % v/v for virus suspended in CM or 80 % v/v for virus suspended in FCS. Each sample was tested in duplicate. Neutralizer was added immediately after the exposure period to prevent or reduce further action of the disinfectant. The volume of neutralizer was 1 ml when the test medium was FCS, but this was increased to 8 ml when the test medium was CM. Freshly split MT-4 cells (4 ml, 105-106 cells/ml) were diluted in CM for tests in FCS and concentrated in FCS for tests in CM to produce a final volume of 10 ml when added to the disinfectant/ neutralizer mixture. The virus was allowed to absorb to the cells by mixing gently on an orbital shaker for 1 h at room temperature. The mixture was centrifuged at 130 g for 10 min, resuspended in 4 ml of CM and 1 ml of this mixture was added to each of 4 wells of 24-well tissue culture plates. The plates were incubated at 37°C in 5 % CO2 and the cultures were examined for a cytopathic effect (CPE) every 3-4 days. Half the volume in each well was replaced with either CM (CPE negative wells) or freshly split cells (CPE positive wells). After 21 days, samples were taken for measurement of p24 antigen levels (DuPont (UK) Ltd, Stevenage, Herts.). An untreated control, where the virus did not come into contact with the disinfectant, was included in each experiment to determine loss of viral activity during the experimental procedure. The disinfectant test concentration was diluted by one tenth at the adsorption stage of the experiment and loss of virus due to residual activity during this step was determined by the inclusion of a second, 'adsorption' control. In both the controls, sodium hypochlorite was substituted by CM. Immediately prior to adding the cell suspension, the disinfectant and neutralizer were added to the adsorption control.
In blood
The protocol described had to be modified when testing in blood. Fresh human blood was collected from healthy volunteers into tubes containing the anticoagulant EDTA and mixed by inverting a minimum of six times. EDTA was chosen since this has been reported to have no effect on the recovery of virus from blood [9] . The standard suspension test protocol was followed, but the red blood cells had to be removed before the adsorption stage to avoid interference in the cytotoxicity assay and problems with the red blood cells masking the CPE in the infectivity assay. The disinfectant was added to the blood/virus mixture in a 2 ml plastic tube and left for the required time. Neutralizer (500 ,ul) was added, the mixture was left for 1 min and centrifuged at 13440 g in a microfuge for 15 s to pellet the red blood cells. The supernatant was added to 9 ml MT-4 cells suspended in FCS, the virus was allowed to adsorb to the cells and the procedure continued as described for FCS. Virus infectivity was indicated by the presence of a CPE and the log TCID50/ml was calculated by the method of Karber [10] .
Cytotoxicity assay
Although the disinfectant was removed from each sample prior to culturing the virus, toxicity to the cells was important during the 1 h adsorption of virus onto the cells. At this stage, the disinfectant had been diluted to a tenth of the final concentration in the viral test mixture. The cytotoxicity of the disinfectant during the adsorption phase was determined prior to virucidal testing. The method used was an adaptation of a colorimetric assay for the growth and survival of cells using a yellow tetrazolium salt which is cleaved by metabolically active cells into a blue formazan product [11] . The amount of cleavage relates directly to the number of metabolically active cells present. The assay initially followed that of the standard assay for inactivation of virus in suspension, but with CM substituted for virus. The final suspension was pipetted into 16 wells of a microtitre plate (100 ,ul per well) and incubated overnight at 37°C in 5 % CO2. The following day 10 ,ul of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Sigma Chemical Company, Poole, Dorset) diluted to 5 g 1-1 was added to each well and the plates incubated at 37°C for 4 h. This allowed metabolism of the yellow dye by the cells, resulting in formation of blue crystals. The reaction was stopped by the addition of 100,tl acid isopropanol (004 M hydrochloric acid in isopropanol). Once the crystals had dissolved completely, the plates were read on a plate reader at 570 nm with a reference wavelength of 630 nm. The mean of the 16 replicates for each set of conditions was calculated and compared as a percentage of the control cells which were taken as 100% metabolic activity. V'alues above 90% were considered to be equivalent to the controls and a disinfectant/neutralizer concentration with a value below 90 % of the metabolic activity of the control cells was taken to be cytotoxic. The disinfectant concentration in the assay is given as the concentration in the test mixture, tenfold higher than the concentration during the adsorption stage when the disinfectant/neutralizer mixture is acting on the cells.
Titration of available chlorine Sodium arsenite method
The total available chlorine contained in the hypochlorite solution as received from the manufacturer, was titrated by the sodium arsenite method [12] 18-24 h prior to each cytotoxicity or virucidal test. The required concentrations of hypochlorite solution were prepared for use the following day and stored in the dark at 4 'C. All solutions were allowed to warm to room temperature before use.
DPD ferrous titrimetric assay
The presence of blood or serum created an indeterminate endpoint in the sodium arsenite method so we used the DPD (N,N-diethyl-p-phenyldiamine) ferrous titrimetric assay [13] to analyse the available chlorine in the disinfectant test mixtures. This method measures both free and combined available chlorine.
The disinfectant test mixture consisted of nine parts test medium to one part sodium hypochlorite. The available chlorine concentration was assayed either immediately or after standing times of 30 or 60 min. The effect of adding neutralizer to the test mixture (at a ratio of 0-5: 1) was also examined after a 1 min contact time. Virucidal assays All virucidal assays were performed at or below the maximum measured noncytotoxic disinfectant/neutralizer concentration. When CFV was tested in CM a reduction in viral titre of over 3 75 log TCID50/ml occurred within 30 s contact time with a maximum concentration of 100 p.p.m. available chlorine in the disinfectant test mixture, representing a stock concentration of 1000 p.p.m. (Table 1 ). When the level of serum was increased to 80% and the maximum concentration of available chlorine was 500 p.p.m. or greater, a reduction of more than 4 0 log TCID50/ml was achieved between 1 and 2 min ( Table 2 ).
In mnarked contrast to the results in serum, in the presence of 80% blood a concentration of 1000 p.p.m. available chlorine in the disinfectant test mixture (representing a concentration of 10000 p.p.m. in the stock solution) was unable to inactivate 3 75 log TCID50/ml of virus (Table 3 ). Testing in blood was problematical at concentrations of available chlorine equal to and above 1000 p.p.m. in the test mixture. Higher concentrations and longer test periods caused haemolysis, partially obscured the pelleted cells and caused difficulty in removing the supernatant. This was particularly evident for a test concentration of 2500 p.p.m. available chlorine, representing a stock concentration of 25000 p.p.m. available chlorine. The amount of virus removed in the adsorption control was low and likely to be an underestimate, although all test results were negative, indicating a minimum inactivation of 1-5 log TCID50/ml.
In view of the problems at higher available chlorine concentrations in 80% blood, we tried 40 % blood as the test medium. In 40 % blood concentrations of 1000 p.p.m. available chlorine in the disinfectant test mixture appeared to inactivate virus at up to 30 min, but not at 60 min (Table 3 ). This apparent contradiction is probably due to inactivation of virus at or around the level of the maximum measurable drop in titre of 2'25 log TCID50/ml. Titration of available chlorine XVe found the arsenite method of chlorine titration to be quick, accurate and reproducible for hypochlorite solutions which did not contain additional protein. However, the presence of protein created an indeterminate endpoint and so the analysis of available chlorine levels in the disinfectant reaction mixtures was by the DPD assay. A large proportion of the available chlorine rapidly became combined in the disinfectant test mixtures, independent of the amount of proteinaceous material present (Table 4 ). Free available chlorine could not be detected in any of the test mixtures containing an initial concentration of 100 p.p.m. available chlorine and was only measurable using 250 p.p.m. available chlorine when blood was used as the test medium. When foetal calf serum was added as a neutralizer, the levels of combined available chlorine decreased further. The standing time of either 30 or 60 min also reduced the levels of combined available chlorine.
DISCUSSION
The methods described in this study have attempted to address the factors so often ignored or inadequately dealt with in disinfectant testing. A high concentration of organic matter was used as the test medium to simulate worstcase conditions and prior to virucidal testing, suitable neutralizers were assessed for their ability to eliminate cytotoxicity prior to virucidal testing.
Data on the inactivation of HIV' by sodium hypochlorite and sodium dichloroisocyanurate (NaDCC) are summarized in Table 5 , although differences in experimental design such as the assay system used to measure presence of virus, the protein load and the form of neutralization if any, permit only limited comparisons between these studies. In addition, caution should be exercised in the interpretation of results if the available chlorine content of the hypochlorite stock solution and/or test solutions are not reported to have been quantified at the time c; x i3 S OO £ W of the experiments. Prior determination of the available chlorine content in the product tested or the resulting solutions is a necessary requirement for all tests with hypochlorite solutions since the available chlorine content decreases with time, especially if the solutions have been kept in the warm and exposed to light [12, 14, 15] . Bloomfield and colleagues [16] are the only other group who have both examined the inactivation of HIV by sodium hypochlorite and reported titration of their test solutions to determine the precise concentration of available chlorine.
The neutralization of disinfectant activity without cytotoxicity after the exposure period may be approached in several ways, such as by dilution or by the addition of a chemical neutralizer. Sodium thiosulphate has been used widely as a neutralizing agent of sodium hypochlorite in bactericidal studies [17] [18] [19] [20] [21] [22] .
Bloomfield and colleagues [16] used sodium thiosulphate plus dilution in saline (500 fold) for 10 min to achieve neutralization of NaDCC granules prior to sampling small aliquots for HIV activity. We also used sodium thiosulphate to neutralize the disinfectant in our test mixtures. Nevertheless, some disinfectant/ neutralizer concentrations which did not have a toxic effect on the cells were toxic to the virus at high levels of available chlorine, indicated by a marked difference between the titre of the untreated control and that of the adsorption control. Although we have a good means of measuring cytotoxicity, we do not have a standard method of preventing it.
Virucidal disinfectant tests must, as far as possible, be applicable to the in vivo situation. If feasible, the titre of virus tested should equal or preferably exceed the maximum titre found in blood and body fluids. The maximum amount of infectious HIV detected in blood is approximately 104 virions per ml [23, 24] . The interpretation of disinfectant efficacy becomes difficult if the test contained a low quantity of virus. In the Bloomfield study on NaDCC granules [16] , the sample examined for viral infectivity would have contained a maximum of only 100 viral particles. This low bioburden was cited by the authors as an explanation for their findings of complete HIV inactivation which differed from their previous experiments in a bacteriological test system. These suggested that 10000 p.p.m. available chlorine may be insufficient for decontamination of bacterial pathogens unless applied at v/v ratios of at least nine parts hypochlorite solution to one part blood [25] .
When chlorine reacts with proteinaceous material, some of the chlorine is taken up to form N-chloro compounds, giving a reserve of combined chlorine, and some is lost through oxidative processes. We have shown that the level of available chlorine is reduced rapidly in the presence of additional protein, with a dramatic decrease in the amount of the active agent available to inactivate the virus. This would explain our virucidal results and those of Bloomfield and colleagues [16] which indicate that a high quantity of available chlorine is required for inactivation of HIV in high levels of blood. In some clinical situations, a low ratio of disinfectant to blood may be used. We have shown that, in the presence of 80 % blood, 1000 p.p.m. available chlorine is not effective at inactivating HIV, even after 1 h. Clotted blood poses the additional problem of penetration by the disinfectant; we did not attempt to examine such a model in this study.
The organic load used in disinfectant testing is an important consideration when 576 Inactivation of HIV-1 interpreting results. T'he protein challenge in studies from other workers varies between no protein and 50 % human plasma (Table 5 ) and we have shown dramatic differences in the rate of inactivation in the presence of low and high serum levels and blood. Our observations of rapid HIV inactivation by sodium hypochlorite in low protein conditions (8% serum) agree with studies by other workers [16, [26] [27] [28] [29] [30] . Hence, in a clean environment, chlorine releasing agents should be rapid and effective disinfectants against HIV.
Our results demonstrate clearly the limitations of chlorine based disinfectants against HIV in conditions simulating soiled/dirty contamination. A concentration of 5000 p.p.m. available chlorine may be insufficient for inactivation of HIV in the presence of high levels or organic matter and guidelines recommending this concentration for the disinfection of blood and body fluid spillages should be reconsidered. At a concentration of 10000 p.p.m. available chlorine, the safety margin under conditions of high organic loading may not be excessive. The dramatic difference in the efficacy of sodium hypochlorite in the presence of a high protein load in the form of serum compared to blood is not unexpected, since only 39 % of the total protein content of whole human blood is composed of serum.
Satisfactory disinfection of HIV (quantified as a three to four log reduction) by sodium dichloroisocyanurate at concentrations of 50 p.p.m. and 2500 p.p.m. available chlorine for clean (0 9 % saline) and dirty (0-9 % saline containing 10 % v/v plasma) conditions respectively was reported by Bloomfield and colleagues [16] . Nevertheless, a final concentration of 5000 p.p.m. available chlorine was required in the presence of 50% blood to produce total inactivation off HIV within 2 min. This emphasizes not just the caution which should be applied in the extrapolation of data form tests in serum to the in vivo situation in blood, but also the necessity for thorough cleaning to remove proteinaceous material prior to disinfection.
We have highlighted some of the important factors to be considered when assessing or advising on the use of hypochlorite solutions as disinfectants. Some of the problems encountered when using hypochlorite solutions may be reduced with the use of NaDCC granules. These dissolve in water to give hypochlorous acid, and are stable for much longer than hypochlorite solutions. They produce higher levels of available chlorine and contain effectively any spillages [14, 31] . Another alternative is the use of powders consisting of a mixture of a chlorine-releasing agent with a highly absorbent acrylic resin which absorbs liquid to form a semisolid gel, although Coates and Wilson [32] found them to be better suited to watery spillages than blood. These products should be avoided when disinfecting liquids of low pH (urine and other acidic fluids) in poorly ventilated conditions, due to the release of chlorine gas.
Standard virucidal tests exist in some countries (the AFNOR test in France, the DGM tests in Germany and the dried carrier tests required for EPA approval in the US), but there are no agreed UK protocols in the medical field and no internationally agreed standards. Discussions are underway at the Comite Europeen de Normalisation (CEN) to provide standard European test methods for the virucidal efficacy of chemical disinfectants and antiseptics in the medical and veterinary field. It is hoped that many of the problems in interpretation of the results by different workers would be addressed by the use of such standardized test methods.
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